SUNDAY 13 OCTOBER 2019
Meet the expert sessions
08:00
M06 Hematology - hematopoietic stem cell transplantation
Nikolai Klimko, FECMM, Russia & Tony Pagliuca, United Kingdom
08:00
M07 Molecular diagnostics
Maurizio Sanguinetti, Italy & Dieter Buchheidt, FECMM, Germany
08:00
M08 Surgery / transplantation
Patricia Munoz, Spain & Paolo Grossi, Italy
08:00
M09 Neonates
Thomas Walsh, FECMM, USA & Emmanuel Roilides, FECMM, Greece
08:00
M10 Meet Mr. and Mrs. Fungus
Cornelia Lass-Flörl, FECMM, Austria & Neil Gow, UK
08:50
Plenary session 4 - Top 10 papers in Mycology
08:50
PS4.1 - The clinical and translational perspective
Don Sheppard, Canada
09:20
PS4.2 - The microbiology perspective
Katrien Lagrou, FECMM, Belgium
ECMM Academy and Excellence Centers: A story of success
09:50
ECMM Academy
Katrien Lagrou, FECMM, Belgium
09:55
ECMM Excellence Centers
Cornelia Lass-Flörl, FECMM, Austria
10:00
Coffee break
10:30
Plenary session 5 - ICU - candida infections / Breaking news from Hematology and ICU
10:30
PS5.1 Peritonitis
10:45
PS5.2 Are the new management strategies useful?
Arnaldo Colombo, FECMM, Brazil
11:00
PS5.3 CNS infections
Anna Candoni, Italy
11:15
PS5.4 CMV and aspergillosis in HSCT patients
Johan Maertens, FECMM, Belgium
11:30
Poster session 2
Video session
11:30
V01
11:40
V02
11:50
V03
12:30
Lunch
12:30
Sponsored Diagnostic Symposium
More information on www.timm2019.org/sponsored-symposia
13:00
Sponsored Integrated Symposium 4
More information on www.timm2019.org/sponsored-symposia
14:15
Parallel Symposia 15-19
Symposium 15 Aspergillus in the ICU
14:15
S15.1 Influenza
Joost Wauters, Belgium
14:35
S15.2 Invasive aspergillosis in patients with underlying liver cirrhosis
Juergen Prattes, Austria
14:55
S15.3 Renal failure
Riina Richardson Rautema, FECMM, United Kingdom
15:15
S15.4* Fungal pneumonia in critically ill cirrhotics: Spectrum, Outcomes, Comparison of diagnostic methods and Biomarkers
Pratibha Kale, India
15:25
S15.5* IPAFLU survey: Invasive Aspergillosis among Patients with Severe Influenza in Intensive Care Units
Joost Wauters, Belgium
15:35
S15.6* Trend of Candidemia with Bloodstream infection in Intensive care units from 2006 to 2017: Results from the Korean National Healthcare-associated Infections Surveillance System
Young Hwa Choi, Republic of Korea
Symposium 16 Dermatology
14:15
S16.1 Cutaneous aspergillosis, is it so rare?
Sevtap Arıkan Akdagli, FECMM, Turkey
14:35
S16.2 Is resistance a problem for dermatophytosis?
Pietro Nenoff, Germany
14:55
S16.3 Phaeohyphomycosis
Teresa Martin, Spain
15:15
S16.4 Blastomycosis
Ilan Schwarz, Canada
15:35
S16.5* Galleria mellonella as a novelty model to study host – pathogen interaction in Malassezia furfur CBS 1878
Adriana Marcela Celis Ramírez, Colombia
Symposium 17 HIV associated cryptococcal meningitis
14:15
S17.1 Screening in low-resource areas
Elvis Temfack, Cameroon
14:35
S17.2 Current therapeutic strategies
Olivier Lortholary, France
14:55
S17.3 Towards having antifungal drugs in low-resource areas
Angela Loyse, United Kingdom
15:15
S17.4 Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis
Tihana Bicanic, FECMM, United Kingdom
15:35
S17.5 Current and future clinical trials on HIV-associated cryptococcal meningitis
Tom Harrison, United Kingdom
Symposium 18 Antifungal stewardship in the era of resistance
14:15
14:15
S18.1 Antifungal stewardship: a practical experience in a tertiary care institution
Maricela Valerio, Spain
14:35
S18.2 Stewardship and azole resistant aspergillosis: a challenge for farmer or physician?
Paul Verweij, FECMM, the Netherlands
14:55
S18.3 Rapid diagnosis of fungal infections: Impact on stewardship
Souha Kanj, Lebanon
15:15
S18.4 Mycology laboratory diagnostic capabilities in different areas of the world
Alessandro Pasqualotto, FECMM, Brazil
15:35
S18.5* Optimising antifungal stewardship: An evaluation of candidaemia guideline compliance and clinical outcome
Laura Cottom, United Kingdom
Symposium 19 Pneumocystis
14:15
S19.1 Diagnosis
Alexandre Alanio, FECMM, France
14:35
S19.2 Pneumocystosis and HIV
Joseph Kovacs, USA
14:55
S19.3 Pneumocystosis in non-HIV patients
15:15
S19.4 Pneumocystosis in neonates
Enrique Calderon, Spain
15:35
S19.5* Evaluation of a novel commercial Loop-mediated Isothermal Amplification (LAMP) assay for rapid detection of Pneumocystis jirovecii
Dirk Schmidt, Germany
15:45
Coffee break
16:15
Parallel Symposia 20-24
Symposium 20 Candida auris
16:15
S20.1 Schizophrenic gram negative yeast conquering the world
Jacques Meis, the Netherlands
16:35
S20.2 In the US
Tom Chiller, USA
16:55
S20.3 Outbreak control
Alba Ruiz, Spain
17:15
S20.4 In resource limited countries
Anuradha Chowdhary, FECMM, India
17:35
S20.5* Understanding Echinocandin Activity Towards Candida auris
Milena Kordalewska, USA
Symposium 21 Immunotherapy for opportunistic fungal infections
16:15
S21.1 CAR-T cells, NK cells
Dimitrios Kontoyiannis, FECMM, USA
16:35
S21.2 WBC transfusions
Livio Pagano, FECMM, Italy
16:55
S21.3 Cytokines
George Chamilos, Greece
17:15
S21.4* Novel chimeric antigen receptor T cells for invasive aspergillosis immunotherapy
Michelle Seif, Germany
17:25
S21.5* Comparison of circulating lymphocyte populations CD4+ and CD8+ T cells, B and NK lymphocytes according to the favorable or worsening evolution of patients with pneumocystosis
Eléna Charpentier, France
17:35
S21.6* Glucosylceramides from Lomentospora prolificans Induce Cytokines Production and Increase the Microbicidal Activity of Macrophages
Mariana Ingrid Dutra Silva Xisto, Brazil
Symposium 22 NGS and mycobiota
16:15
S22.1 Bacterial-fungal interactions at the airway mucosa and implications for chronic rhinosinusitis
Emily Cope, USA
16:35
S22.2 Respiratory mycobiome – a clinical perspective
Robert Krause, FECMM, Austria
16:55
S22.3 Characterization of indoor dust microbiota in homes of asthma and non asthma patients
Jean-Pierre Gangneux, FECMM, France
17:15
S22.4 Understanding the role of the gut mycobiome in health and disease
Maria Vehreschild, FECMM, Germany
17:35
S22.5* An ECMM-ESCMID survey on goals and practices for mycobiota characterization using Next Generation Sequencing in European laboratories
Jean-Pierre Gangneux, FECMM, France
Symposium 23 The funny life of C. albicans in the oral tract
16:15
S23.1 Within-host genomic diversity of Candida albicans in healthy carriers.
Marie-Elisabeth Bougnoux, France
16:35
S23.2 Activation oral immune responses by C. albicans
Julian Naglik, UK
16:55
S23.3 Modulation of the fungal-host interaction by the intra-species diversity of C. albicans
Dominique Sanglard, Switzerland
17:15
S23.4 Intestinal Th17 drives airway inflammation in ABPA
Petra Bacher, Germany
17:35
S23.5* Persistence of clonal azole-resistant isolates of Candida albicans from a patient with Chronic Mucocutaneous Candidiasis in Colombia
Andres Ceballos-Garzon, Colombia
Symposium 24 Fungal Neglected Tropical Diseases
16:15
S24.1 Mycetoma
Wendy van de Sande, FECMM, the Netherlands
16:35
S24.2 Chromoblastomycosis
Flavio de Queiroz-Telles, FECMM, Brazil
16:55
S24.3 Sporotrichosis
Leila Lopes Bezerra, Brazil
17:15
S24.4 Novel diagnostic and treatment strategies for the Southeast Asian fungus Talaromyces marneffei
Thuy Le, USA
17:25
S24.5* Urban sporotrichosis: neglected micro-epidemia in the State of Minas Gerais, Brazil
Maria Aparecida Resende Stoianoff, Brazil
Ben De Pauw Lectures (EORTC)
Johan Maertens
Belgium
Thierry Calandra
Switzerland
19:30
Congress dinner